EP
RXST icon

Essential Partners’s RxSight RXST Stock Holding History

Essential Partners’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.57K Sell
1,544
-347
-18% -$2.04K ﹤0.01% 1325
2026
Q2 		$9.12K Buy
1,891
+1,467
+346% +$8.86K ﹤0.01% 1254
2026
Q1 		$2.61K Buy
424
+314
+285% +$2.61K ﹤0.01% 1893
2025
Q4 		$1.15K Buy
110
+108
+5,400% +$1.08K ﹤0.01% 1987
2025
Q3 		$18 Sell
2
-7
-78% -$61 ﹤0.01% 2641
2025
Q2 		$117 Buy
+9
New +$135 ﹤0.01% 2043

Other funds holding RXST

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Armstrong Advisory Group
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners's RXST Position: Q3 2026 in Review

Essential Partners reduced its RxSight (RXST) stake by 18% in Q3 2026, selling an estimated $2.04K and leaving 1,544 shares worth $7.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Essential Partners first reported a position in RXST in Q2 2025 and has held it in 6 quarters since. The position peaked at $9.12K in Q2 2026. 10 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Essential Partners held 1,544 shares of RxSight worth $7.57K as of Q3 2026.
  • Essential Partners sold 347 RxSight shares in Q3 2026, an estimated $2.04K.
  • RxSight made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1325 holding.
  • Essential Partners first reported a position in RxSight in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's RxSight position peaked at $9.12K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.